Latest Regulatory News

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.

Barton Gold Holdings has advanced its South Australian gold assets with key drilling upgrades, a low-cost mill restart feasibility study, and a $15 million equity placement led by Franklin Templeton. The company is poised to transition from explorer to producer by late 2026.

Taiton Resources has completed key soil sampling programs targeting gold and rare earth elements at its South Australian projects, alongside heritage surveys and regulatory steps, supported by a recent $2 million capital raise.

Rimfire Pacific Mining is set to begin an 85-hole infill drilling program at its Murga Exploration Target, aiming to convert it into a mineral resource by early 2026 and significantly expand its scandium inventory.

ACDC Metals reports promising mineralogy results from its Goschen Central Project, highlighting valuable rare earth elements and heavy minerals. The company maintains a solid cash balance and advances its retention licence application, positioning itself well in the evolving rare earth sector.

Sarytogan Graphite Limited reports strong progress in graphite and copper exploration, securing key DFS contracts and a $3.6 million placement to advance its flagship projects.

Globe Metals & Mining advances its Kanyika Niobium Project with a regulatory extension, licence expansion to new critical minerals, and a significant capital raise, positioning the company for its next development phase.

Osmond Resources has extended the known strike of critical mineral-bearing quartzite layers at its Orión Project in Spain through successful step-out drilling, setting the stage for upcoming assay results and resource evaluation.

TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.

Yugo Metals has raised $3.5 million to fund its first-ever diamond drilling program targeting gold anomalies at its Sinjakovo project in Bosnia. The company also advances community and regulatory engagement for its Sockovac license while maintaining a cautious cash position.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.